Motus GI Holdings (MOTS) Stock Soars 46% On  FDA Clearance News

MOTS stock is one of the notable stock gainers in the pre-market session after Motus GI Holdings Inc (NASDAQ:MOTS) announced today that it has received FDA Clearance to Market the Pure-Vu® System for Upper GI Endoscopy.

The company stated that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for a version of the Pure-Vu® System that is compatible with gastroscopes used during upper gastrointestinal (GI) endoscopy procedures to remove blood, blood clots and debris in order to provide a clear field-of-view for the endoscopist.

Related:  AnPac Bio-Medical Science (ANPC) More Than Doubles Amid Validating COVID-19 Antibody Test

This proprietary technology is the latest innovation for the Pure-Vu System platform that is specifically designed to integrate with therapeutic gastroscopes to enable safe and rapid cleansing during the procedure, while preserving established procedural workflow and techniques.

It’s a positive news and investors are reacting accordingly. The stock pre-market trading signals that the MOTS stock will gap up by 46% at $1.59.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.